A panelist discusses a typical lower-risk myelodysplastic syndrome case managed with luspatercept over ...

Discover the competitive landscape of Myelodysplastic Syndrome (MDS) therapeutics. With 498,757 cases in 2024 and a slight increase by 2029, the report reveals a robust pipeline of 262 molecules ...

Many individuals living with myelodysplastic syndromes experience debilitating symptoms that affect their ability to manage daily tasks and enjoy life. In both phase 1 and 2 trials, bexmarilimab and ...

Five people living with myelodysplastic syndromes (MDS) or in survivorship talk about their experiences with this serious and commonly misunderstood group of conditions. Myelodysplastic syndromes ...

Marie Brewer, a social worker with the Leukemia & Lymphoma Society (LLS) describes how family members and caregivers can advocate for their loved ones with myelodysplastic syndromes (MDS).

The researchers found that seven of 67 patients developed hematologic cancer after receipt of eli-cel: Myelodysplastic syndrome (MDS) with unilineage dysplasia developed in two patients at 14 and ...

One patient developed myelodysplastic syndrome ... The three patients with MDS with excess blasts and one patient with MDS with unilineage dysplasia underwent allogeneic HSCT.

The researchers found that seven of 67 patients developed hematologic cancer after receipt of eli-cel: Myelodysplastic syndrome (MDS) with unilineage dysplasia developed in two patients at 14 and 26 ...

15. Germing U, Strupp C, Giagounidis A, Haas R, Gattermann N, Starke C, et al. Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic ...